Document Detail


Improving the efficacy of type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells.
MedLine Citation:
PMID:  21567289     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Type 1 diabetes occurs when pancreatic islet β-cells are damaged and are thus unable to secrete insulin. Pancreas- or islet-grafting therapy offers highly efficient treatment but is limited by inadequate donor islets or pancreases for transplantation. Stem-cell therapy holds tremendous potential and promises to enhance treatment efficiency by overcoming the limitations of traditional therapies. In this study, we evaluated the efficiency of preclinical diabetic treatment. Diabetes was induced in mice by injections of streptozotocin. Mesenchymal stem cells (MSCs) were derived from mouse bone marrow or human umbilical cord blood and subsequently differentiated into insulin-producing cells. These insulin-producing cells were encapsulated in an alginate membrane to form capsules. Finally, these capsules were grafted into diabetic mice by intraperitoneal injection. Treatment efficiency was evaluated by monitoring body weight and blood glucose levels. Immune reactions after transplantation were monitored by counting total white blood cells. Allografting or xenografting of encapsulated insulin-producing cells (IPCs) reduced blood glucose levels and increased body weight following transplantation. Encapsulation with alginate conferred immune isolation and prevented graft rejection. These results provide further evidence supporting the use of allogeneic or xenogeneic MSCs obtained from bone marrow or umbilical cord blood for treating type 1 diabetes.
Authors:
Phan Kim Ngoc; Pham Van Phuc; Truong Hai Nhung; Duong Thanh Thuy; Nguyen Thi Minh Nguyet
Related Documents :
2681139 - Diabetic heart disease--current problems and their management.
18776159 - Histopathology of the urinary bladders of cynomolgus monkeys treated with ppar agonists.
2341999 - Changes in eating attitudes during the first year of treatment for diabetes.
21676459 - The impact of hyperglycemia and the presence of encapsulated islets on oxygenation with...
21719559 - Systematic kidney disease management in a population with diabetes mellitus: turning th...
21501149 - Correlation between insulin requirements and anti-galactose antibodies in patients with...
16958239 - The relationship between diabetic retinopathy, glycemic control, risk factor indicators...
6380309 - Intrahepatic glucose: a requirement for neonatal odc induction by specific hormones.
20216389 - Role of intraoperative and postoperative blood glucose concentrations in predicting out...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-13
Journal Detail:
Title:  Human cell : official journal of Human Cell Research Society     Volume:  -     ISSN:  1749-0774     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8912329     Medline TA:  Hum Cell     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Laboratory of Stem Cell Research and Application, University of Science, Vietnam National University, 227 Nguyen Van Cu, District 5, Ho Chi Minh, Vietnam.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chemisorptions effect of oxygen on the geometries, electronic and magnetic properties of small size ...
Next Document:  Peroxisomal hydroxypyruvate reductase is not essential for photorespiration in Arabidopsis but its a...